Related Experiment Videos
Polymorphisms in glycine transporter with schizophrenia.
Shih-Jen Tsai1, Chih-Ya Cheng, Chen-Jee Hong
1Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
Summary
Genetic variations in the glycine transporter (GlyT1) gene are not associated with schizophrenia in the Chinese population. This study suggests GlyT1 polymorphisms do not significantly contribute to schizophrenia susceptibility.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- N-methyl-D-aspartate (NMDA) receptor hypofunction is linked to schizophrenia.
- Glycine transporter 1 (GlyT1) regulates glycine availability, an NMDA receptor co-agonist.
- Genetic factors influencing GlyT1 may impact schizophrenia risk.
Purpose of the Study:
- To investigate the association between GlyT1 genetic variants and schizophrenia susceptibility.
- To determine if GlyT1 polymorphisms confer risk for schizophrenia in the Chinese population.
Main Methods:
- Genotyping of three GlyT1 polymorphisms (rs1766967, rs2248632, rs2248253) in 249 schizophrenia patients and 210 controls.
- Chi-square tests and haplotype analysis were used to assess associations.
- Linkage disequilibrium analysis was performed.
Main Results:
- No significant association was found between individual GlyT1 markers and schizophrenia.
- Haplotype analysis did not reveal a significant link between GlyT1 variants and schizophrenia.
- One polymorphism (rs16831541) was not informative in the study population.
Conclusions:
- The investigated GlyT1 polymorphisms are unlikely to play a substantial role in schizophrenia susceptibility in the Chinese population.
- Further research on other GlyT1 variants and their relation to schizophrenia is warranted.
- Exploring GlyT1's role in psychotic symptoms and treatment response is suggested.